Drugs / pNGVL4a-Sig/E7(detox)/HSP70
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00121173 | Nov 2003 → Jan 2010 | cervical cancer, precancerous condition | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pNGVL4a-Sig/E7(detox)/HSP70 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00121173 ↗ |
| Modality | Vaccine | “recombinant DNA vaccine” NCT00121173 ↗ |
| Route | Intramuscular | “administered IM at one month intervals” NCT00121173 ↗ |